ABSTRACT
To identify molecules involved in neurogenesis, we have raised monoclonal antibodies against embryonic day 12.5 mouse telencephalon. One antibody, monoclonal antibody 25H11, stains predominantly the ventricular zone of the anterior and lateral telencephalon. Purification of the 25H11 antigen, a 47 kDa integral membrane protein, from approximately 2500 mouse telencephali reveals its identity with ephrin B1. Ephrin B1 appears at the onset of neocortical neurogenesis, being first expressed in neuron-generating neuroepithelial cells and rapidly thereafter in virtually all neuroepithelial cells. Expression of ephrin B1 persists through the period of neocortical neurogenesis and is downregulated thereafter. Ephrin B1 is present on the ventricular as well as basolateral plasma membrane of neuroepithelial cells and exhibits an ventricular-high to pial-low gradient across the ventricular zone. Expression of ephrin B1 is also detected on radial glial cells, extending all the way to their pial endfeet, and on neurons in the mantle/intermediate zone but not in the cortical plate. Our results suggest that ephrin B1, presumably via ephrin-Eph receptor signaling, has a role in neurogenesis. Given the ventricular-to-pial gradient of ephrin B1 on the neuroepithelial cell surface and its known role in cell migration in other systems mediated by its repulsive properties, we propose that ephrin B1 may be involved in the migration of newborn neurons out from the ventricular zone toward the neocortex.
Subject(s)
Epithelial Cells/metabolism , Membrane Proteins/biosynthesis , Neurons/metabolism , Telencephalon/embryology , Telencephalon/metabolism , Animals , Antibodies, Monoclonal/isolation & purification , Antibodies, Monoclonal/metabolism , Antibody Specificity , Antigens, Differentiation/biosynthesis , Antigens, Differentiation/chemistry , Antigens, Differentiation/immunology , Cell Membrane/metabolism , Cell Movement/physiology , Cerebral Ventricles/cytology , Cerebral Ventricles/embryology , Cerebral Ventricles/metabolism , Ephrin-B1 , Ephrin-B2 , Ephrin-B3 , Epithelial Cells/cytology , Gene Expression Regulation, Developmental , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Mice , Mice, Inbred Strains , Molecular Weight , Morphogenesis/physiology , Neocortex/cytology , Neocortex/embryology , Neocortex/metabolism , Neuroglia/cytology , Neuroglia/metabolism , Neurons/cytology , Organ Specificity , Pia Mater/cytology , Pia Mater/embryology , Pia Mater/metabolism , Rats , Signal Transduction/physiology , Telencephalon/cytologyABSTRACT
At the onset of mammalian neurogenesis, neuroepithelial (NE) cells switch from proliferative to neuron-generating divisions. Understanding the molecular basis of this switch requires the ability to distinguish between these two types of division. Here we show that in the mouse ventricular zone, expression of the mRNA of the antiproliferative gene TIS21 (PC3, BTG2) (i) starts at the onset of neurogenesis, (ii) is confined to a subpopulation of NE cells that increases in correlation with the progression of neurogenesis, and (iii) is not detected in newborn neurons. Expression of the TIS21 mRNA in the NE cells occurs transiently during the cell cycle, i.e., in the G1 phase. In contrast to the TIS21 mRNA, the TIS21 protein persists through the division of NE cells and is inherited by the neurons, where it remains detectable during neuronal migration and the initial phase of differentiation. Our observations indicate that the TIS21 gene is specifically expressed in those NE cells that, at their next division, will generate postmitotic neurons, but not in proliferating NE cells. Using TIS21 as a marker, we find that the switch from proliferative to neuron-generating divisions is initiated in single NE cells rather than in synchronized neighboring cells.
Subject(s)
Central Nervous System/embryology , Gene Expression Regulation, Developmental , Genes, Tumor Suppressor , Immediate-Early Proteins/genetics , Neurons/physiology , Transcription, Genetic , Animals , Animals, Newborn , COS Cells , Cell Cycle Proteins/biosynthesis , Cell Cycle Proteins/genetics , Cell Division , Central Nervous System/cytology , Central Nervous System/metabolism , Epithelial Cells/cytology , Epithelial Cells/physiology , Epitopes/analysis , Immediate-Early Proteins/biosynthesis , Mice , Neurons/cytology , RNA, Messenger/analysis , RNA, Messenger/genetics , Recombinant Proteins/biosynthesis , Transfection , Tumor Suppressor ProteinsABSTRACT
Activation of Myc triggers a rapid induction of cyclin E/cdk2 kinase activity and degradation of p27. Overt degradation of p27 is preceded by a specific dissociation of p27 from cyclin E/cdk2, but not from cyclin D/cdk4 complexes. We now show that cyclin E/cdk2 phosphorylates p27 at a carboxy-terminal threonine residue (T187) in vitro; mutation of this residue to valine stabilises cyclin E/cdk2 complexes. This reaction is not significantly inhibited by high concentrations of p27, suggesting that cdk2 bound to p27 is catalytically active. In vivo, p27 bound to cyclins E and A, but not to D-type cyclins is phosphorylated. Myc-induced release of p27 from cdk2 requires cdk2 kinase activity and is delayed in a T187V mutant of p27. After induction of Myc, p27 phosphorylated at threonine 187 transiently accumulates in a non cdk2 bound form. Our data suggest a mechanism in which p27 is released from cyclin E/cdk2 upon phosphorylation; in Myc-transformed cells, release is efficient as phosphorylated p27 is transiently bound in a non-cdk2 containing complex and subsequently degraded.
